South Cone Investments Limited Partnership, 10% Owner at Rani Therapeutics Holdings, Inc. (RANI), bought 19,250 shares at $5.20 ($101K) on 2023-02-15, disclosed to the SEC on 2023-02-16.
Open-market purchase of $101k RANI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.25 | 9,250 | $49K | 48.3% |
| 2 | $5.20 | 10,000 | $52K | 51.7% |
| Total | $5.22 avg | 19,250 | $101K | 100% |
| Filing → |
| RANI | BUY | 2023-12-08 | $21.2M | — | Filing → |
| RANI | BUY | 2023-05-05 | $10K | — | Filing → |
| RANI | BUY | 2023-05-02 | $10K | — | Filing → |